What a crap show this stock is.
Impossible to make money with it. Let's see if things have changed.
Impossible to make money with it. Let's see if things have changed.
Recent ARTL News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/27/2026 08:39:45 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/26/2026 09:03:39 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/26/2026 08:47:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 05/20/2026 04:15:18 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2026 08:00:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2026 08:06:33 PM
- Artelo Biosciences Provides Business Update Outlining Upcoming Milestones and Reports 2026 First Quarter Financial Results • GlobeNewswire Inc. • 05/14/2026 08:05:00 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 05/14/2026 08:00:32 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 05/04/2026 08:44:49 PM
- Artelo Biosciences Announces Strategic Collaboration with Artificial Intelligence (AI) Leader ScienceMachine Highlighting New Expansion Opportunities and Insights for FABP5 Inhibitor Development • GlobeNewswire Inc. • 04/28/2026 12:25:00 PM
- Artelo Announces Peer-Reviewed Publication Supporting its FABP5 Inhibitor ART26.12 as a Novel Pain Treatment with a Potentially First-in-Class Profile • GlobeNewswire Inc. • 04/20/2026 11:50:00 AM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 04/07/2026 08:18:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 12:00:10 PM
- Artelo Biosciences Regains Compliance with Nasdaq Listing Requirements • GlobeNewswire Inc. • 04/07/2026 11:50:00 AM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 04/03/2026 08:46:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/30/2026 09:35:26 PM
- Artelo Biosciences Announces Closing of $11.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules • GlobeNewswire Inc. • 03/30/2026 08:46:00 PM
